Compare SAIA & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAIA | BIO |
|---|---|---|
| Founded | 1924 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.2B |
| IPO Year | 2002 | N/A |
| Metric | SAIA | BIO |
|---|---|---|
| Price | $342.88 | $307.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | $342.59 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 517.8K | 158.4K |
| Earning Date | 10-30-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 10.58 | N/A |
| Revenue | ★ $3,233,286,000.00 | $2,557,500,000.00 |
| Revenue This Year | $2.18 | $1.77 |
| Revenue Next Year | $4.97 | $2.30 |
| P/E Ratio | $32.61 | ★ N/A |
| Revenue Growth | ★ 1.96 | N/A |
| 52 Week Low | $229.12 | $211.43 |
| 52 Week High | $545.12 | $373.69 |
| Indicator | SAIA | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 73.46 | 44.85 |
| Support Level | $324.61 | $307.08 |
| Resistance Level | $358.50 | $319.50 |
| Average True Range (ATR) | 13.83 | 8.47 |
| MACD | 6.34 | -1.43 |
| Stochastic Oscillator | 85.37 | 6.82 |
Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.